| Serial Number | 79402419 |
| Word Mark | TCR BODY |
| Filing Date | Monday, April 15, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, October 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the designed "TCR BodY". |
| Goods and Services | Developing products for others; research and development of new products; consulting services in the field of technology development; scientific research and development; research in the field of biochemistry; laboratory and industrial analysis in the field of biochemistry; research and development of antibodies; development of pharmaceutical preparations and pharmaceuticals; pharmaceutical research; biomedical research; drug development. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Thursday, August 15, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 20, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 1, 2024 | REFUSAL PROCESSED BY MPU |
| Saturday, October 19, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, October 1, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, August 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 25, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, September 26, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |